Net

I have been using the @Gemini Credit Card since October 2025 and look at much $BTC I have gotten in cash back! With 4% cash back on transportation it’s amazing to have in NYC especially for the subway. To learn more about the card use my link here: creditcard.exchange.gemini.com/credit-card/ap…

$RDDT is about to cook

@prospero_ai IT LOOKS SO GOOD RIGHT NOW

@NetWorthNotes Bullish momentum is beginning to form for $RDDT in the Prospero Signals 👀 A broader market push could send this stock higher again. Full outlook below 👇

Pay attention to $RDDT

@TRob405 @Pure_Calls Worse to buy not a huge fan of financials

@Pure_Calls @NetWorthNotes Is that worse to buy right now, or the best buy right now? 🤔🤔

Worst sector to buy in the market right now?

@NeedleStrat $BE has gone up so much hard to find an entry

@NetWorthNotes Yeo for example… I would not buy $TSLA $OKLO or $BE here no matter how much I like the theoretical benefits.

And you don’t trust $VOO?

@DGretta_Author Never been a fan of food stocks

@NetWorthNotes food

@Pure_Calls Been rough this year

@NetWorthNotes Financial

@NeedleStrat Can you give an example?

@NetWorthNotes High-multiple, low opacity

@simplecentsco You stacking cash?

@NetWorthNotes All of them…

@TheStockerMan And then it will soar!

@NetWorthNotes If they meet their 2026 guidance… The re-rate will happen.

$OSCR is a stock where I think you have to separate the one-year noise from the bigger business build. 2025 looked ugly on the surface because $OSCR medical loss ratio rose to 87.4% from 81.7%, and the company swung from 57.3M of earnings from operations in 2024 to a 396.4M operating loss in 2025. That is exactly the kind of result that scares people out of the name. But then you look at what management is guiding for in 2026: 18.7B-19.0B of total revenue, an 82.4%-83.4% medical loss ratio, and 250M-$450M of earnings from operations. That is a massive expected turn. To me, that is the real debate with $OSCR right now. Do you believe 2025 was the sign that the model is broken, or do you believe it was a painful reset year inside a business that is still scaling and can earn real money when utilization and risk adjustment normalize? I lean toward the second camp. The market still treats $OSCR like it is just another volatile insurtech… but if they actually deliver that 2026 setup, this starts looking much more like a maturing healthcare platform with serious earnings power than people want to give it credit for. At around $13 right now, I honestly think the market is just waiting to see if $OSCR can actually hit that 2026 guidance. If they do, I think this stock runs.

@SparkingFIRENC Index funds are good to buy anytime bro 😎

@NetWorthNotes But I just bought more 😬

Well time to stack cash it will get much worse…

@theepi1980 Fr

@NetWorthNotes I am happy that my shares stays with me.

Mr. Market is giving more and more opportunities to buy $RDDT at a great price! Would love to buy a lot at $120

Bro you can’t make this up. HOW DO YOU INVEST IN SOMETHING WITH $0 REVENUE. HOW DO YOU GO PUBLIC 😭😭

@Miko_776 Fr

@NetWorthNotes In Jensen we trust

If Jensen executes this then $NVDA will easily be a $400+ stock in no time. Wow what a bold claim. It’s my No.1 position and it will stay there for the foreseeable future

@stoicxtrades $OSCR is a very solid buy

@NetWorthNotes Right now in this moment $SMR and $OSCR

Anyone else worried a bit about $SOFI for the short term?